Julia Heinrich
About Julia Heinrich
Julia Heinrich is a Senior Patent Analyst in Biotechnology at Bristol-Myers Squibb with extensive experience in both academic and industry settings.
Title
Julia Heinrich is currently a Senior Patent Analyst in Biotechnology at Bristol-Myers Squibb, based in Hopewell, NJ.
Professional Background
Julia Heinrich has held various roles in her extensive career, beginning as a Research Assistant at UMass Medical School & Brown University in 1977. She has worked at Memorial Sloan Kettering Cancer Center as a PhD Candidate, and later as a Postdoctoral Fellow at Bristol-Myers Squibb. She contributed significantly as a Principal Research Scientist at Wyeth Research for 14 years and as a Patent Information Analyst at sanofi-aventis. Additionally, she has engaged in leadership roles at AWIS-NJ and participated actively in professional groups such as PIUG and Toastmasters International.
Education and Expertise
Julia Heinrich has a robust educational background, having studied Biology at Brown University, Molecular Biology and Virology at Cornell University, and Biochemistry and Molecular Biology at Memorial Sloan Kettering. She also completed courses in Drug Metabolism at the University of California, San Diego, and Grantwriting Essentials at Mercer County Community College. Furthermore, she earned a Mini-MBA Certificate in BioPharma Innovations from Rutgers University.
Teaching and Leadership Roles
Julia Heinrich has been a Guest Lecturer at Rutgers University for a decade, sharing her knowledge in biotechnology and patent analysis. She also served as the Secretary for the NYAS-BPDG at the New York Academy of Sciences. Heinrich has held multiple leadership positions at AWIS-NJ, including president twice, secretary, and treasurer. She has been an active member of Toastmasters International and Princeton Toastmasters, achieving CC & CL designations.
Contributions to Biotechnology and Patent Analysis
With over a decade of experience in biotechnology patent analysis, Julia Heinrich has contributed significantly to the field. Her role at Bristol-Myers Squibb involves advanced research in biotechnology, benefiting from her extensive background in molecular biology, virology, and biochemistry. She participated in the Text Mining Summit organized by Linguamatics I2E for five consecutive years, showcasing her commitment to staying at the forefront of technological advancements in her field.